These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 26464442)
21. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC. Reed DE; Shokat KM Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852 [TBL] [Abstract][Full Text] [Related]
22. Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate. Shenker BJ; Walker LP; Zekavat A; Boesze-Battaglia K Mol Oral Microbiol; 2016 Feb; 31(1):33-42. PubMed ID: 26299277 [TBL] [Abstract][Full Text] [Related]
23. PIP3-binding proteins promote age-dependent protein aggregation and limit survival in C. elegans. Ayyadevara S; Balasubramaniam M; Johnson J; Alla R; Mackintosh SG; Shmookler Reis RJ Oncotarget; 2016 Aug; 7(31):48870-48886. PubMed ID: 27429199 [TBL] [Abstract][Full Text] [Related]
24. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy. Saintigny P; Mitani Y; Pytynia KB; Ferrarotto R; Roberts DB; Weber RS; Kies MS; Maity SN; Lin SH; El-Naggar AK Cancer; 2018 Sep; 124(18):3693-3705. PubMed ID: 30289966 [TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor α induces down-regulation of PTEN through PI3-kinase activation in breast cancer cells. Noh EM; Lee YR; Chay KO; Chung EY; Jung SH; Kim JS; Youn HJ Mol Med Rep; 2011; 4(2):215-9. PubMed ID: 21468554 [TBL] [Abstract][Full Text] [Related]
26. PIP3 pathway in regulatory T cells and autoimmunity. Kashiwada M; Lu P; Rothman PB Immunol Res; 2007; 39(1-3):194-224. PubMed ID: 17917066 [TBL] [Abstract][Full Text] [Related]
27. Phosphoinositide 3-kinase targeting by the beta galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death. Wells V; Mallucci L Breast Cancer Res; 2009; 11(1):R2. PubMed ID: 19133120 [TBL] [Abstract][Full Text] [Related]
36. Phosphatidylinositol-3,4,5-trisphosphate: tool of choice for class I PI 3-kinases. Salamon RS; Backer JM Bioessays; 2013 Jul; 35(7):602-11. PubMed ID: 23765576 [TBL] [Abstract][Full Text] [Related]
37. Class I PI 3-kinases: Function and evolution. Kriplani N; Hermida MA; Brown ER; Leslie NR Adv Biol Regul; 2015 Sep; 59():53-64. PubMed ID: 26159297 [TBL] [Abstract][Full Text] [Related]
38. Chemotaxis in the absence of PIP3 gradients. Hoeller O; Kay RR Curr Biol; 2007 May; 17(9):813-7. PubMed ID: 17462897 [TBL] [Abstract][Full Text] [Related]
39. Phosphatidylinositol-3-OH kinase signalling is spatially organized at endosomal compartments by microtubule-associated protein 4. Thapa N; Chen M; Horn HT; Choi S; Wen T; Anderson RA Nat Cell Biol; 2020 Nov; 22(11):1357-1370. PubMed ID: 33139939 [TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. Phillips RJ; Mestas J; Gharaee-Kermani M; Burdick MD; Sica A; Belperio JA; Keane MP; Strieter RM J Biol Chem; 2005 Jun; 280(23):22473-81. PubMed ID: 15802268 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]